Hims & Hers Health, Inc. (HIMS) EV/Sales Ratio: 3.06x
Is Hims & Hers Health, Inc.’s EV/Sales ratio high or low?
Hims & Hers Health, Inc.'s EV/Sales ratio of 3.06x is 28% below its 5-year average of 4.27x, near the low end of its 5-year range (1.60x–12.89x).
As of Thursday, June 11, 2026. 35.32% below its 12-month average of 4.73x.
HIMS EV/Sales Ratio Chart
HIMS Average EV/Sales Ratio Chart
HIMS Current vs Average EV/Sales Ratio Chart
HIMS EV/Sales Ratio Metrics
EV/SALES RATIO
3.06x
EV/SALES RATIO AVG TTM
4.73x
EV/SALES RATIO AVG 3Y
4.20x
EV/SALES RATIO AVG 5Y
4.27x
EV/SALES RATIO AVG 10Y
4.29x
EV/SALES RATIO AVG 15Y
4.29x
EV/SALES RATIO AVG 20Y
4.29x
CURRENT VS TTM AVG
-35.32%
CURRENT VS 3Y AVG
-27.19%
CURRENT VS 5Y AVG
-28.39%
CURRENT VS 10Y AVG
-28.64%
CURRENT VS 15Y AVG
-28.64%
CURRENT VS 20Y AVG
-28.64%
HIMS Competitors' EV/Sales Ratio
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Hims & Hers Health, Inc. (HIMS) | $6.19B | 3.06x | 4.73x | 4.20x | 4.27x |
| Bio-Rad Laboratories, Inc. (BIO) | $7.92B | 3.41x | 3.41x | 3.67x | 4.57x |
| Charles River Laboratories International, Inc. (CRL) | $8.94B | 2.97x | 2.79x | 3.02x | 3.79x |
| Baxter International Inc. (BAX) | $10.49B | 1.60x | 1.72x | 2.17x | 2.64x |
| Align Technology, Inc. (ALGN) | $12.27B | 2.75x | 2.73x | 4.07x | 5.91x |
| Hologic, Inc. (HOLX) | $16.97B | 4.25x | 4.02x | 4.39x | 4.15x |
| Moderna, Inc. (MRNA) | $18.71B | 8.10x | 5.96x | 5.02x | 6.82x |
| BioNTech SE (BNTX) | $22.39B | 3.24x | 4.19x | 3.71x | 3.49x |
| Mettler-Toledo International Inc. (MTD) | $22.82B | 6.13x | 7.35x | 7.51x | 8.18x |
| Waters Corporation (WAT) | $23.21B | 9.27x | 7.03x | 7.13x | 7.32x |
Understanding EV/Sales
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
- It works for unprofitable companies where P/E doesn't apply
- Revenue is harder to manipulate than earnings
- It supports comparisons across companies at different profitability stages
- It is frequently used for software and other revenue-growth-focused companies
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
Hims & Hers Health, Inc. EV/Sales Ratio Formula & Definition
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Hims & Hers Health, Inc. EV/Sales Ratio FAQ
- What is the EV/Sales ratio for Hims & Hers Health, Inc. (HIMS)?
- The EV/Sales ratio for HIMS stock is 3.06x.
- Is Hims & Hers Health, Inc.'s EV/Sales ratio high or low?
- Hims & Hers Health, Inc.'s EV/Sales ratio of 3.06x is 28% below its 5-year average of 4.27x, near the low end of its 5-year range (1.60x–12.89x).
- What is the TTM average EV/Sales ratio for Hims & Hers Health, Inc. (HIMS)?
- The TTM average EV/Sales ratio for HIMS stock is 4.73x.
- What is the 3Y average EV/Sales ratio for Hims & Hers Health, Inc. (HIMS)?
- The 3Y average EV/Sales ratio for HIMS stock is 4.20x.
- What is the 5Y average EV/Sales ratio for Hims & Hers Health, Inc. (HIMS)?
- The 5Y average EV/Sales ratio for HIMS stock is 4.27x.
- What is the 10Y average EV/Sales ratio for Hims & Hers Health, Inc. (HIMS)?
- The 10Y average EV/Sales ratio for HIMS stock is 4.29x.
- What is the 15Y average EV/Sales ratio for Hims & Hers Health, Inc. (HIMS)?
- The 15Y average EV/Sales ratio for HIMS stock is 4.29x.
- What is the 20Y average EV/Sales ratio for Hims & Hers Health, Inc. (HIMS)?
- The 20Y average EV/Sales ratio for HIMS stock is 4.29x.
Hims & Hers Health, Inc. EV/Sales Ratio History
| DATE | EV/SALES RATIO |
|---|---|
| 2026-06-11 | 3.06x |
| 2026-06-10 | 3.06x |
| 2026-06-09 | 3.18x |
| 2026-06-08 | 3.00x |
| 2026-06-05 | 2.91x |
| 2026-06-04 | 3.08x |
| 2026-06-03 | 3.03x |
| 2026-06-02 | 3.03x |
| 2026-06-01 | 3.06x |
| 2026-05-29 | 2.90x |
| 2026-05-28 | 2.83x |
| 2026-05-27 | 2.81x |
| 2026-05-26 | 2.68x |
| 2026-05-22 | 2.67x |
| 2026-05-21 | 2.70x |
| 2026-05-20 | 2.60x |
| 2026-05-19 | 2.55x |
| 2026-05-18 | 2.53x |
| 2026-05-15 | 2.80x |
| 2026-05-14 | 2.72x |
| 2026-05-13 | 2.71x |
| 2026-05-12 | 2.80x |
| 2026-05-11 | 3.19x |
| 2026-05-08 | 3.43x |
| 2026-05-07 | 3.15x |
| 2026-05-06 | 3.28x |
| 2026-05-05 | 3.22x |
| 2026-05-04 | 3.32x |
| 2026-05-01 | 3.34x |
| 2026-04-30 | 3.31x |
| 2026-04-29 | 3.22x |
| 2026-04-28 | 3.39x |
| 2026-04-27 | 3.55x |
| 2026-04-24 | 3.67x |
| 2026-04-23 | 3.42x |
| 2026-04-22 | 3.51x |
| 2026-04-21 | 3.59x |
| 2026-04-20 | 3.72x |
| 2026-04-17 | 3.49x |
| 2026-04-16 | 3.29x |
| 2026-04-15 | 3.01x |
| 2026-04-14 | 2.70x |
| 2026-04-13 | 2.68x |
| 2026-04-10 | 2.49x |
| 2026-04-09 | 2.53x |
| 2026-04-08 | 2.49x |
| 2026-04-07 | 2.50x |
| 2026-04-06 | 2.59x |
| 2026-04-02 | 2.46x |
| 2026-04-01 | 2.54x |
| 2026-03-31 | 2.63x |
| 2026-03-30 | 2.43x |
| 2026-03-27 | 2.49x |
| 2026-03-26 | 2.65x |
| 2026-03-25 | 2.64x |
| 2026-03-24 | 2.70x |
| 2026-03-23 | 2.81x |
| 2026-03-20 | 2.77x |
| 2026-03-19 | 2.99x |
| 2026-03-18 | 2.89x |
| 2026-03-17 | 3.08x |
| 2026-03-16 | 3.07x |
| 2026-03-13 | 3.06x |
| 2026-03-12 | 2.96x |
| 2026-03-11 | 3.18x |
| 2026-03-10 | 2.92x |
| 2026-03-09 | 2.78x |
| 2026-03-06 | 2.10x |
| 2026-03-05 | 2.12x |
| 2026-03-04 | 2.18x |
| 2026-03-03 | 2.11x |
| 2026-03-02 | 2.18x |
| 2026-02-27 | 1.98x |
| 2026-02-26 | 2.09x |
| 2026-02-25 | 2.11x |
| 2026-02-24 | 2.07x |
| 2026-02-23 | 2.08x |
| 2026-02-20 | 2.11x |
| 2026-02-19 | 2.13x |
| 2026-02-18 | 2.13x |
| 2026-02-17 | 2.18x |
| 2026-02-13 | 2.18x |
| 2026-02-12 | 2.13x |
| 2026-02-11 | 2.23x |
| 2026-02-10 | 2.29x |
| 2026-02-09 | 2.52x |
| 2026-02-06 | 2.94x |
| 2026-02-05 | 2.99x |
| 2026-02-04 | 3.09x |
| 2026-02-03 | 3.22x |
| 2026-02-02 | 3.32x |
| 2026-01-30 | 3.40x |
| 2026-01-29 | 3.71x |
| 2026-01-28 | 3.57x |
| 2026-01-27 | 3.69x |
| 2026-01-26 | 3.75x |
| 2026-01-23 | 3.68x |
| 2026-01-22 | 3.78x |
| 2026-01-21 | 3.60x |
| 2026-01-20 | 3.78x |
| 2026-01-16 | 3.88x |
| 2026-01-15 | 3.86x |
| 2026-01-14 | 3.87x |
| 2026-01-13 | 3.97x |
| 2026-01-12 | 3.99x |
| 2026-01-09 | 3.91x |
| 2026-01-08 | 4.16x |
| 2026-01-07 | 4.34x |
| 2026-01-06 | 4.34x |
| 2026-01-05 | 4.25x |
| 2026-01-02 | 4.11x |
| 2025-12-31 | 4.00x |
| 2025-12-30 | 4.07x |
| 2025-12-29 | 4.18x |
| 2025-12-26 | 4.21x |
| 2025-12-24 | 4.25x |
| 2025-12-23 | 4.26x |
| 2025-12-22 | 4.29x |
| 2025-12-19 | 4.35x |
| 2025-12-18 | 4.26x |
| 2025-12-17 | 4.28x |
| 2025-12-16 | 4.50x |
| 2025-12-15 | 4.43x |
| 2025-12-12 | 4.53x |
| 2025-12-11 | 4.60x |
| 2025-12-10 | 4.61x |
| 2025-12-09 | 4.83x |
| 2025-12-08 | 4.75x |
| 2025-12-05 | 4.76x |
| 2025-12-04 | 4.85x |
| 2025-12-03 | 4.52x |
| 2025-12-02 | 4.43x |
| 2025-12-01 | 4.57x |
| 2025-11-28 | 4.82x |
| 2025-11-26 | 4.67x |
| 2025-11-25 | 4.52x |
| 2025-11-24 | 4.60x |
| 2025-11-21 | 4.25x |
| 2025-11-20 | 4.13x |
| 2025-11-19 | 4.38x |
| 2025-11-18 | 4.43x |
| 2025-11-17 | 4.35x |
| 2025-11-14 | 4.51x |
| 2025-11-13 | 4.40x |
| 2025-11-12 | 4.74x |
| 2025-11-11 | 4.82x |
| 2025-11-10 | 4.97x |
| 2025-11-07 | 4.96x |
| 2025-11-06 | 5.02x |
| 2025-11-05 | 5.27x |
| 2025-11-04 | 5.16x |
| 2025-11-03 | 5.34x |
| 2025-10-31 | 5.76x |
| 2025-10-30 | 5.58x |
| 2025-10-29 | 5.91x |
| 2025-10-28 | 5.97x |
| 2025-10-27 | 6.11x |
| 2025-10-24 | 6.18x |
| 2025-10-23 | 6.14x |
| 2025-10-22 | 6.01x |
| 2025-10-21 | 6.25x |
| 2025-10-20 | 6.51x |
| 2025-10-17 | 6.31x |
| 2025-10-16 | 7.50x |
| 2025-10-15 | 7.96x |
| 2025-10-14 | 6.85x |
| 2025-10-13 | 6.94x |
| 2025-10-10 | 6.84x |
| 2025-10-09 | 7.39x |
| 2025-10-08 | 7.38x |
| 2025-10-07 | 7.35x |
| 2025-10-06 | 6.94x |
| 2025-10-03 | 6.66x |
| 2025-10-02 | 7.34x |
| 2025-10-01 | 7.14x |
| 2025-09-30 | 7.19x |
| 2025-09-29 | 7.50x |
| 2025-09-26 | 7.41x |
| 2025-09-25 | 6.96x |
| 2025-09-24 | 6.75x |
| 2025-09-23 | 7.10x |
| 2025-09-22 | 7.32x |
| 2025-09-19 | 7.33x |
| 2025-09-18 | 7.13x |
| 2025-09-17 | 6.38x |
| 2025-09-16 | 6.45x |
| 2025-09-15 | 6.84x |
| 2025-09-12 | 7.04x |
| 2025-09-11 | 6.56x |
| 2025-09-10 | 6.05x |
| 2025-09-09 | 6.05x |
| 2025-09-08 | 6.29x |
| 2025-09-05 | 6.13x |
| 2025-09-04 | 6.10x |
| 2025-09-03 | 5.63x |
| 2025-09-02 | 5.26x |
| 2025-08-29 | 5.36x |
| 2025-08-28 | 5.59x |
| 2025-08-27 | 5.57x |
| 2025-08-26 | 5.74x |
| 2025-08-25 | 5.44x |
| 2025-08-22 | 5.64x |
| 2025-08-21 | 5.57x |
| 2025-08-20 | 5.49x |
| 2025-08-19 | 5.34x |
| 2025-08-18 | 5.71x |
| 2025-08-15 | 5.83x |
| 2025-08-14 | 5.97x |
| 2025-08-13 | 6.12x |
| 2025-08-12 | 6.08x |
| 2025-08-11 | 6.33x |
| 2025-08-08 | 6.58x |
| 2025-08-07 | 6.47x |
| 2025-08-06 | 6.48x |
| 2025-08-05 | 7.04x |
| 2025-08-04 | 8.04x |
| 2025-08-01 | 8.53x |
| 2025-07-31 | 9.03x |
| 2025-07-30 | 8.94x |
| 2025-07-29 | 8.21x |
| 2025-07-28 | 7.99x |
| 2025-07-25 | 7.85x |
| 2025-07-24 | 7.80x |
| 2025-07-23 | 7.90x |
| 2025-07-22 | 6.79x |
| 2025-07-21 | 6.46x |
| 2025-07-18 | 6.84x |
| 2025-07-17 | 6.79x |
| 2025-07-16 | 7.05x |
| 2025-07-15 | 6.86x |
| 2025-07-14 | 7.07x |
| 2025-07-11 | 6.50x |
| 2025-07-10 | 6.83x |
| 2025-07-09 | 6.96x |
| 2025-07-08 | 6.65x |
| 2025-07-07 | 6.57x |
| 2025-07-03 | 6.51x |
| 2025-07-02 | 6.44x |
| 2025-07-01 | 6.51x |
| 2025-06-30 | 6.77x |
| 2025-06-27 | 6.71x |
| 2025-06-26 | 6.28x |
| 2025-06-25 | 5.61x |
| 2025-06-24 | 5.82x |
| 2025-06-23 | 5.68x |
| 2025-06-20 | 8.76x |
| 2025-06-18 | 8.32x |
| 2025-06-17 | 8.07x |
| 2025-06-16 | 8.14x |
| 2025-06-13 | 7.55x |
| 2025-06-12 | 7.78x |
| 2025-06-11 | 7.84x |
| 2025-06-10 | 7.52x |
| 2025-06-09 | 7.74x |
| 2025-06-06 | 7.67x |
| 2025-06-05 | 7.18x |
| 2025-06-04 | 7.29x |
| 2025-06-03 | 7.45x |
| 2025-06-02 | 7.73x |
| 2025-05-30 | 7.70x |
Showing the most recent 260 of 1,560 data points. The chart above shows the full history.
Related Metrics
About Hims & Hers Health, Inc.
Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.
- Sector
- Healthcare
- Industry
- Medical - Equipment & Services
- CEO
- Andrew Dudum